Biovista is a pioneer of systematic drug repositioning.We apply our systematic discovery platform to develop our pipeline of repositioned drug candidates in neurodegenerative diseases, epilepsy, oncology and orphan diseases.Our scientists use Biovista’s technology platform to analyze massive data re…
Biovista is a pioneer of systematic drug repositioning.
We apply our systematic discovery platform to develop our pipeline of repositioned drug candidates in neurodegenerative diseases, epilepsy, oncology and orphan diseases.
Our scientists use Biovista’s technology platform to analyze massive data resources and identify non-obvious, mechanism-of-action based associations between compounds, molecular targets and diseases.
We use this insight to find new uses for existing drugs or drug combinations, assess their risk profile and advance them to PoC and Clinical Phase IIa/b sooner, cheaper and with a higher probability of success than has been possible to date.
Team (1)
Sectors Biovista serves:
Life Sciences
Join Axial's Private M&A Platform
Biovista connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
